Findings
Organizational challenges such as risk-averse corporate culture and lack of strategy hinder PT adoption.
Business-related challenges include unclear ROI and limited willingness to invest.
External challenges involve regulatory implications and technology landscape issues.
Internal disconnections within companies lead to inefficiencies in PT initiatives.

Recommendations
Improve understanding and communication between all clinical trial stakeholders.
Engage with sites and patients to inform trial design.
Address internal disconnections within companies to facilitate PT adoption.
Develop a clear business case for PT to encourage investment.
Enhance training and support for technology use in clinical trials.

Regulatory Considerations
Lack of specific guidance for PT use in clinical trials.
Geographic variability in regulations and interpretations.
Privacy and security concerns related to data management.